1182 related articles for article (PubMed ID: 30036453)
1. Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review.
Narayan V; Kahlmeyer A; Dahm P; Skoetz N; Risk MC; Bongiorno C; Patel N; Hwang EC; Jung JH; Gartlehner G; Kunath F
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012838. PubMed ID: 30036453
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for advanced or metastatic urothelial carcinoma.
Maisch P; Hwang EC; Kim K; Narayan VM; Bakker C; Kunath F; Dahm P
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013774. PubMed ID: 37811690
[TBL] [Abstract][Full Text] [Related]
3. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
4. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
5. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.
Kunath F; Jensen K; Pinart M; Kahlmeyer A; Schmidt S; Price CL; Lieb V; Dahm P
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD003506. PubMed ID: 31194882
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy for metastatic renal cell carcinoma.
Hofmann F; Hwang EC; Lam TB; Bex A; Yuan Y; Marconi LS; Ljungberg B
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012796. PubMed ID: 33058158
[TBL] [Abstract][Full Text] [Related]
7. Robotic versus open radical cystectomy for bladder cancer in adults.
Rai BP; Bondad J; Vasdev N; Adshead J; Lane T; Ahmed K; Khan MS; Dasgupta P; Guru K; Chlosta PL; Aboumarzouk OM
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011903. PubMed ID: 31016718
[TBL] [Abstract][Full Text] [Related]
8. Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.
Sathianathen NJ; Philippou YA; Kuntz GM; Konety BR; Gupta S; Lamb AD; Dahm P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012816. PubMed ID: 30320443
[TBL] [Abstract][Full Text] [Related]
9. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
[TBL] [Abstract][Full Text] [Related]
10. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T; Csőszi T; Özgüroğlu M; Matsubara N; Géczi L; Cheng SY; Fradet Y; Oudard S; Vulsteke C; Morales Barrera R; Fléchon A; Gunduz S; Loriot Y; Rodriguez-Vida A; Mamtani R; Yu EY; Nam K; Imai K; Homet Moreno B; Alva A;
Lancet Oncol; 2021 Jul; 22(7):931-945. PubMed ID: 34051178
[TBL] [Abstract][Full Text] [Related]
11. Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer.
Schmidt S; Kunath F; Coles B; Draeger DL; Krabbe LM; Dersch R; Kilian S; Jensen K; Dahm P; Meerpohl JJ
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011935. PubMed ID: 31912907
[TBL] [Abstract][Full Text] [Related]
12. Robot-assisted vs open radical cystectomy for bladder cancer in adults.
Rai BP; Bondad J; Vasdev N; Adshead J; Lane T; Ahmed K; Khan MS; Dasgupta P; Guru K; Chlosta PL; Aboumarzouk OM
BJU Int; 2020 Jun; 125(6):765-779. PubMed ID: 31309688
[TBL] [Abstract][Full Text] [Related]
13. Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.
Patel A; Kalachand R; Busschots S; Doherty B; Kapros E; Lawlor D; Hall N; Stordal BK
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008766. PubMed ID: 35866378
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 blocking agents for treating COVID-19: a living systematic review.
Ghosn L; Chaimani A; Evrenoglou T; Davidson M; Graña C; Schmucker C; Bollig C; Henschke N; Sguassero Y; Nejstgaard CH; Menon S; Nguyen TV; Ferrand G; Kapp P; Riveros C; Ávila C; Devane D; Meerpohl JJ; Rada G; Hróbjartsson A; Grasselli G; Tovey D; Ravaud P; Boutron I
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013881. PubMed ID: 33734435
[TBL] [Abstract][Full Text] [Related]
15. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.
Tomita Y; Moldovan M; Chang Lee R; Hsieh AH; Townsend A; Price T
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012078. PubMed ID: 33210731
[TBL] [Abstract][Full Text] [Related]
16. Intravesical electromotive drug administration for non-muscle invasive bladder cancer.
Jung JH; Gudeloglu A; Kiziloz H; Kuntz GM; Miller A; Konety BR; Dahm P
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011864. PubMed ID: 28898400
[TBL] [Abstract][Full Text] [Related]
17. Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma.
Hwang EC; Sathianathen NJ; Jung JH; Kim MH; Dahm P; Risk MC
Cochrane Database Syst Rev; 2019 May; 5(5):CD013160. PubMed ID: 31102534
[TBL] [Abstract][Full Text] [Related]
18. Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant.
Langer P; John L; Monsef I; Scheid C; Piechotta V; Skoetz N
Cochrane Database Syst Rev; 2024 May; 5(5):CD013595. PubMed ID: 38695605
[TBL] [Abstract][Full Text] [Related]
19. Clinically-indicated replacement versus routine replacement of peripheral venous catheters.
Webster J; Osborne S; Rickard CM; Marsh N
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007798. PubMed ID: 30671926
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
Tattersall A; Ryan N; Wiggans AJ; Rogozińska E; Morrison J
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD007929. PubMed ID: 35170751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
